Brain Res

1. CANSIZ D, Unal I, Gani Surmen M, Surmen S, et al
   Gentisic acid exerts neuroprotective effects in neurotoxin-induced Parkinson's disease model in zebrafish: Cross-talk between pathways related with neurodegeneration in the gut-brain axis.
   Brain Res. 2024 Apr 19:148952. doi: 10.1016/j.brainres.2024.148952.
   

   >> Share

   
   
2. MA LY, Jia B, Geng H, Liang J, et al
   Poly(rC)-binding protein 1 alleviates neurotoxicity in 6-OHDA-induced SH-SY5Y cells and modulates glial cells in neuroinflammation.
   Brain Res. 2024;1832:148863.
   

   >> Share

   
   

   
   Exp Neurol

3. FERREIRA AFF, Ulrich H, Feng ZP, Sun HS, et al
   Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model.
   Exp Neurol. 2024;377:114780.
   

   >> Share

   
   

   
   J Neural Transm (Vienna)

4. PIRAMIDE N, De Micco R, Di Nardo F, Caiazzo G, et al
   Altered domain-specific striatal functional connectivity in patients with Parkinson's disease and urinary symptoms.
   J Neural Transm (Vienna). 2024 Apr 25. doi: 10.1007/s00702-024-02776.
   

   >> Share

   
   

   
   Mov Disord

5. STEINA A, Sure S, Butz M, Vesper J, et al
   Mapping Subcortico-Cortical Coupling-A Comparison of Thalamic and Subthalamic Oscillations.
   Mov Disord. 2024;39:684-693.
   

   >> Share

   
   
6. KORNILOV E, Baker Erdman H, Kahana E, Fireman S, et al
   Interleaved Propofol-Ketamine Maintains DBS Physiology and Hemodynamic Stability: A Double-Blind Randomized Controlled Trial.
   Mov Disord. 2024;39:694-705.
   

   >> Share

   
   
7. PATEL J, Dawson VL, Dawson TM
   Blocking the Self-Destruct Program of Dopamine Neurons through Macrophage Migration Inhibitory Factor Nuclease Inhibition.
   Mov Disord. 2024;39:644-650.
   

   >> Share

   
   
8. FREQUIN HL, Verschuur CVM, Suwijn SR, Boel JA, et al
   Long-Term Follow-Up of the LEAP Study: Early Versus Delayed Levodopa in Early Parkinson's Disease.
   Mov Disord. 2024 Apr 21. doi: 10.1002/mds.29796.
   

   >> Share

   
   
9. KLUGE A, Schaeffer E, Bunk J, Sommerauer M, et al
   Detecting Misfolded alpha-Synuclein in Blood Years before the Diagnosis of Parkinson's Disease.
   Mov Disord. 2024 Apr 23. doi: 10.1002/mds.29766.
   

   >> Share

   
   
10. XIE T, Warnke PC
    Comment on: "A Transatlantic Viewpoint on the Role of Pallidal Stimulation for Parkinson's Disease".
    Mov Disord. 2024;39:760-761.
    

    >> Share

    
    
11. BOOGERS A, Fasano A
    Reply to: Comment on: A Transatlantic Viewpoint on the Role of Pallidal Stimulation for Parkinson's Disease.
    Mov Disord. 2024;39:761.
    

    >> Share

    
    
12. PETERS J, Maamary J, Kyle K, Olsen N, et al
    Reply to: Recurrence of Parkinson's Disease Tremor after Focused Ultrasound Thalamotomy?
    Mov Disord. 2024;39:759-760.
    

    >> Share

    
    
13. ONDER H
    Recurrence of Parkinson's Disease Tremor after Focused Ultrasound Thalamotomy?
    Mov Disord. 2024;39:758-759.
    

    >> Share

    
    
14. SENKEVICH K, Miliukhina I, Zhuravlev A, Shumilova M, et al
    Autosomal Dominant Parkinson's Disease Caused by SNCA p.E46K Mutation in a Family with Russian Ancestry.
    Mov Disord. 2024 Apr 25. doi: 10.1002/mds.29821.
    

    >> Share

    
    
15. MONCHI O, Pinilla-Monsalve GD, Almgren H, Ghahremani M, et al
    White Matter Microstructural Underpinnings of Mild Behavioral Impairment in Parkinson's Disease.
    Mov Disord. 2024 Apr 25. doi: 10.1002/mds.29804.
    

    >> Share

    
    
16. DODET P, Houot M, Leu-Semenescu S, Gaurav R, et al
    Isolated REM Sleep without Atonia Is Not Equivalent to REM Sleep Behavior Disorder in Early-Stage Parkinson's Disease.
    Mov Disord. 2024 Apr 26. doi: 10.1002/mds.29813.
    

    >> Share

    
    

    
    Nat Med

17. MULIYIL S
    Repurposing a diabetes drug to treat Parkinson's disease.
    Nat Med. 2024 Apr 20. doi: 10.1038/d41591-024-00026.
    

    >> Share

    
    

    
    Neurobiol Dis

18. TREMBLAY C, Aslam S, Walker JE, Lorenzini I, et al
    RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction.
    Neurobiol Dis. 2024 Apr 23:106514. doi: 10.1016/j.nbd.2024.106514.
    

    >> Share

    
    
19. BUOSO C, Seifert M, Lang M, Griffith CM, et al
    Dopamine?iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease.
    Neurobiol Dis. 2024 Apr 20:106506. doi: 10.1016/j.nbd.2024.106506.
    

    >> Share

    
    
20. TONG B, Ba Y, Li Z, Yang C, et al
    Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
    Neurobiol Dis. 2024 Apr 18:106505. doi: 10.1016/j.nbd.2024.106505.
    

    >> Share

    
    

    
    PLoS Biol

21. WU D, Sun JK, Chow KH
    Neuronal cell cycle reentry events in the aging brain are more prevalent in neurodegeneration and lead to cellular senescence.
    PLoS Biol. 2024;22:e3002559.
    

    >> Share

    
    

    
    PLoS One

22. MORACA GAG, Orcioli-Silva D, Legutke BR, Gutierrez PP, et al
    Aerobic exercise on the treadmill combined with transcranial direct current stimulation on the gait of people with Parkinson's disease: A protocol for a randomized clinical trial.
    PLoS One. 2024;19:e0300243.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share